iohexol has been researched along with Brain Neoplasms in 23 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The validated method has been successfully applied to a pharmacokinetic study of thermosensitive liposome-encapsulated lomustine containing iohexol and lomustine solution after intravenous administration to C6 glioma rats." | 7.77 | HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats. ( Derendorf, H; Gao, J; Li, M; Liu, C; Yu, F; Zeng, Y; Zhang, B; Zhuang, L, 2011) |
| " The validated method has been successfully applied to a pharmacokinetic study of thermosensitive liposome-encapsulated lomustine containing iohexol and lomustine solution after intravenous administration to C6 glioma rats." | 3.77 | HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats. ( Derendorf, H; Gao, J; Li, M; Liu, C; Yu, F; Zeng, Y; Zhang, B; Zhuang, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zu, Z | 1 |
| Li, H | 1 |
| Jiang, X | 1 |
| Gore, JC | 1 |
| Chae, SY | 1 |
| Suh, S | 1 |
| Ryoo, I | 1 |
| Park, A | 1 |
| Noh, KJ | 1 |
| Shim, H | 1 |
| Seol, HY | 1 |
| Shankar, JJ | 1 |
| Woulfe, J | 1 |
| Silva, VD | 1 |
| Nguyen, TB | 1 |
| Chen, T | 1 |
| Guo, D | 1 |
| Fang, Z | 1 |
| Zhong, W | 1 |
| Zhao, J | 1 |
| Jiang, Y | 1 |
| Zhuang, L | 1 |
| Gao, J | 1 |
| Zeng, Y | 1 |
| Yu, F | 1 |
| Zhang, B | 1 |
| Li, M | 1 |
| Derendorf, H | 1 |
| Liu, C | 1 |
| Zipp, L | 1 |
| Schwartz, KM | 1 |
| Hewer, E | 1 |
| Yu, Y | 1 |
| Stippich, C | 1 |
| Slopis, JM | 1 |
| Yeung, TP | 1 |
| Yartsev, S | 1 |
| Bauman, G | 1 |
| He, W | 1 |
| Fainardi, E | 1 |
| Lee, TY | 2 |
| Huang, WY | 1 |
| Zhang, BY | 1 |
| Geng, DY | 1 |
| Zhang, J | 1 |
| Roberts, HC | 1 |
| Roberts, TP | 1 |
| Dillon, WP | 1 |
| Koh, TS | 2 |
| Tan, CK | 1 |
| Cheong, LH | 1 |
| Lim, CC | 2 |
| Hayakawa, K | 1 |
| Shiozaki, T | 1 |
| Yamamoto, A | 1 |
| Kubo, S | 1 |
| Osako, T | 1 |
| Bisdas, S | 1 |
| Yang, X | 1 |
| Vogl, TJ | 1 |
| Thron, A | 1 |
| Ratzka, M | 1 |
| Voigt, K | 1 |
| Nadjmi, M | 1 |
| Nakstad, P | 1 |
| Sortland, O | 1 |
| Aaserud, O | 1 |
| Nicoletti, GF | 1 |
| Barone, F | 1 |
| Passanisi, M | 1 |
| Mancuso, P | 1 |
| Albanese, V | 1 |
| Albert, FK | 1 |
| Forsting, M | 1 |
| Sartor, K | 1 |
| Adams, HP | 1 |
| Kunze, S | 1 |
| Allen, ED | 1 |
| Byrd, SE | 1 |
| Darling, CF | 1 |
| Tomita, T | 1 |
| Wilczynski, MA | 1 |
| Puskás, Z | 1 |
| Schuierer, G | 1 |
| Sighvatsson, V | 1 |
| Ericson, K | 1 |
| Tómasson, H | 1 |
| Fujiwara, T | 1 |
| Tanohata, K | 1 |
| Onishi, T | 1 |
| Matsui, K | 1 |
| Grzyska, U | 1 |
| Freitag, J | 1 |
| Zeumer, H | 1 |
| Langer, M | 1 |
| Felix, R | 1 |
| Behrends, B | 1 |
| Eichstädt, H | 1 |
| Fike, JR | 1 |
| Cann, CE | 1 |
| Turowski, K | 1 |
| Norman, D | 1 |
| Ax, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| CT Perfusion in the Prognostication of Cerebral High Grade Glioma[NCT01923922] | 100 participants (Anticipated) | Interventional | 2013-09-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for iohexol and Brain Neoplasms
| Article | Year |
|---|---|
Comparative study of vascular enhancement on post-contrast CT using three dosages of iodinated contrast media for the aim of detecting brain metastasis in patients with lung cancer.
Topics: Adult; Aged; Analysis of Variance; Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Hum | 2006 |
Iohexol and ioxaglate in cerebral angiography.
Topics: Adult; Aged; Brain Injuries; Brain Neoplasms; Cerebral Angiography; Cerebrovascular Disorders; Clini | 1983 |
Iohexol compared to meglumine-Ca-metrizoate in common carotid angiography. A randomized double blind cross-over study in man.
Topics: Adolescent; Adult; Aged; Brain Diseases; Brain Neoplasms; Cerebral Angiography; Contrast Media; Doub | 1983 |
Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis.
Topics: Brain Neoplasms; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Female; Follow-Up S | 1994 |
19 other studies available for iohexol and Brain Neoplasms
| Article | Year |
|---|---|
Spin-lock imaging of exogenous exchange-based contrast agents to assess tissue pH.
Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Glioblastoma; Hydrogen-Ion Concentration; Iohexol; | 2018 |
A semi-automated volumetric software for segmentation and perfusion parameter quantification of brain tumors using 320-row multidetector computed tomography: a validation study.
Topics: Adult; Aged; Algorithms; Blood Volume; Brain Neoplasms; Contrast Media; Female; Humans; Iohexol; Mal | 2017 |
Evaluation of perfusion CT in grading and prognostication of high-grade gliomas at diagnosis: a pilot study.
Topics: Brain Neoplasms; Cerebral Angiography; Contrast Media; Female; Glioma; Humans; Iohexol; Male; Middle | 2013 |
Preliminary study of whole-brain CT perfusion imaging in patients with intracranial tumours adjacent to large blood vessels.
Topics: Adult; Aged; Blood Flow Velocity; Blood Volume; Brain Neoplasms; Cerebral Angiography; Cerebrovascul | 2014 |
HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Brain Neoplasms; Calibration; Cell Line, Tumor; Ch | 2011 |
Magnetic resonance imaging and computed tomography findings in pediatric giant cell glioblastoma.
Topics: Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cerebral Ventricles; Child; Contrast Media; Diffusion Ma | 2012 |
The effect of scan duration on the measurement of perfusion parameters in CT perfusion studies of brain tumors.
Topics: Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Female; Glioma; Humans; Iohexol; Male; | 2013 |
Computed tomography and magnetic resonance features of extraventricular neurocytoma: a study of eight cases.
Topics: Adolescent; Adult; Age Distribution; Brain; Brain Mapping; Brain Neoplasms; Calcinosis; Child; Contr | 2013 |
Dynamic contrast-enhanced computed tomography (CT) for quantitative estimation of microvascular permeability in human brain tumors.
Topics: Adenocarcinoma; Aged; Blood Volume; Brain Neoplasms; Capillary Permeability; Contrast Media; Female; | 2002 |
Cerebral perfusion mapping using a robust and efficient method for deconvolution analysis of dynamic contrast-enhanced images.
Topics: Adenoma; Aged; Artifacts; Blood Flow Velocity; Blood Volume; Brain; Brain Neoplasms; Contrast Media; | 2006 |
Delineation and segmentation of cerebral tumors by mapping blood-brain barrier disruption with dynamic contrast-enhanced CT and tracer kinetics modeling-a feasibility study.
Topics: Blood Volume; Blood-Brain Barrier; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Fea | 2008 |
Linear contrast enhancement at the operative site on early post-operative CT after removal of brain tumors.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Cerebellar Neoplasms; Combined Modalit | 1994 |
The clinical and radiological evaluation of primary brain neoplasms in children, Part II: Radiological evaluation.
Topics: Brain; Brain Neoplasms; Cerebral Angiography; Child; Child, Preschool; Gadolinium; Humans; Infant; I | 1993 |
[Determination of blood circulation time for optimizing contrast medium administration in CT angiography].
Topics: Adult; Aged; Blood Flow Velocity; Brain; Brain Neoplasms; Carotid Stenosis; Cerebral Angiography; Co | 1996 |
Optimising contrast-enhanced cranial CT for detection of brain metastases.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Follow-Up Studies; Humans; Injectio | 1998 |
Extravasation of contrast medium into the subdural space during cavernous sinus venography: a rare complication.
Topics: Brain Neoplasms; Cavernous Sinus; Cerebral Angiography; Extravasation of Diagnostic and Therapeutic | 1992 |
Selective cerebral intraarterial DSA. Complication rate and control of risk factors.
Topics: Adult; Aged; Angiography, Digital Subtraction; Brain Neoplasms; Cerebral Angiography; Cerebrovascula | 1990 |
[Use of nonionic contrast media in computerized tomography].
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Neoplasms; Female; Humans; Iohexol; Male; Midd | 1987 |
Contrast enhancement of brain tumors and irradiated normal brain: a comparison of iohexol and iothalamate.
Topics: Animals; Brain; Brain Neoplasms; Dogs; Ependymoma; Iodine Radioisotopes; Iodobenzoates; Iohexol; Iot | 1986 |